Merit Medical Systems, Inc. (MMSI)
NASDAQ: MMSI · Real-Time Price · USD
97.84
-0.24 (-0.24%)
Dec 26, 2024, 10:34 AM EST - Market open
Merit Medical Systems Revenue
Merit Medical Systems had revenue of $339.85M in the quarter ending September 30, 2024, with 7.81% growth. This brings the company's revenue in the last twelve months to $1.33B, up 8.12% year-over-year. In the year 2023, Merit Medical Systems had annual revenue of $1.26B with 9.24% growth.
Revenue (ttm)
$1.33B
Revenue Growth
+8.12%
P/S Ratio
4.29
Revenue / Employee
$190,773
Employees
6,950
Market Cap
5.70B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 1.26B | 106.39M | 9.24% |
Dec 31, 2022 | 1.15B | 76.23M | 7.09% |
Dec 31, 2021 | 1.07B | 110.88M | 11.50% |
Dec 31, 2020 | 963.88M | -30.98M | -3.11% |
Dec 31, 2019 | 994.85M | 112.10M | 12.70% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
RadNet | 1.77B |
Stevanato Group | 1.22B |
Ionis Pharmaceuticals | 803.07M |
Inspire Medical Systems | 755.59M |
Tempus AI | 640.44M |
Corcept Therapeutics | 628.56M |
Blueprint Medicines | 434.42M |
BridgeBio Pharma | 217.77M |
MMSI News
- 6 days ago - Merit Medical Announces FDA Approval of the WRAPSODY Cell-Impermeable Endoprosthesis - GlobeNewsWire
- 9 days ago - Merit Medical Announces Resignation of President, Joseph Wright - GlobeNewsWire
- 4 weeks ago - Fundus Camera Market Global Forecasts and Company Analysis 2025-2033, Profiles of Carl Zeiss Medites, Topcon Medical Systems, Merit Medical Systems, NIDEK, and Revenio Group - GlobeNewsWire
- 4 weeks ago - Merit Medical's WRAPSODY WAVE Trial Exceeds Performance Goals for Arteriovenous Graft (AVG) Patients - GlobeNewsWire
- 7 weeks ago - Merit Medical Completes Acquisition of Lead Management Portfolio from Cook Medical - GlobeNewsWire
- 2 months ago - Merit Medical Systems, Inc. (MMSI) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Merit Medical Systems to Announce Third Quarter 2024 Results on October 30, 2024 - GlobeNewsWire
- 3 months ago - Merit Medical Signs Agreement to Purchase Lead Management Portfolio from Cook Medical - GlobeNewsWire